The digital health revolution is still stuck.
Tech giants are jumping into the fray with fitness offerings like Apple Health and Google Fit, but there’s still not much in the way of, well, actual medicine. The Fitbits and Jawbones of the world measure users’ steps and heart rate, but they don’t get into the deep diagnostics of, say, biomarkers, the internal indicators that can serve as an early warning sign of a serious ailment. For now, those who want to screen for a disease or measure a medical condition with clinical accuracy still need to go to the doctor.
Dr. Eugene Chan and his colleagues at the DNA Medical Institute (DMI) aim to change that. Chan’s team has created a portable handheld device that can diagnose hundreds of diseases using a single drop of blood with what Chan claims is gold-standard accuracy. Known as rHEALTH, the technology was developed over the course of seven years with grants from NASA, the National Institutes of Health, and the Bill and Melinda Gates Foundation. On Monday, the team received yet another nod (and more funding) as the winners of this year’s Nokia Sensing XChallenge, one of several competitions run by the moonshot-seeking XPrize Foundation.
No comments:
Post a Comment